| Literature DB >> 12648452 |
Michael F Princiotta1, Diana Finzi, Shu-Bing Qian, James Gibbs, Sebastian Schuchmann, Frank Buttgereit, Jack R Bennink, Jonathan W Yewdell.
Abstract
Using L929 cells, we quantitated the macroeconomics of protein synthesis and degradation and the microeconomics of producing MHC class I associated peptides from viral translation products. To maintain a content of 2.6 x 10(9) proteins, each cell's 6 x 10(6) ribosomes produce 4 x 10(6) proteins min(-1). Each of the cell's 8 x 10(5) proteasomes degrades 2.5 substrates min(-1), creating one MHC class I-peptide complex for each 500-3000 viral translation products degraded. The efficiency of complex formation is similar in dendritic cells and macrophages, which play a critical role in activating T cells in vivo. Proteasomes create antigenic peptides at different efficiencies from two distinct substrate pools: rapidly degraded newly synthesized proteins that clearly represent defective ribosomal products (DRiPs) and a less rapidly degraded pool in which DRiPs may also predominate.Mesh:
Substances:
Year: 2003 PMID: 12648452 DOI: 10.1016/s1074-7613(03)00051-7
Source DB: PubMed Journal: Immunity ISSN: 1074-7613 Impact factor: 31.745